SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase

Reuters

2025/07/17

SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase

SoftMedx Healthcare Limited has published its audited financial results for the year ended 31 December 2024. The company reported a 6.4% increase in revenue, reaching HK$54.6 million, compared to HK$51.3 million in the previous year. This growth was primarily driven by the company's efforts to expand its product offerings by obtaining new product sources. Despite facing challenges from shifting consumer preferences and competitive market conditions, SoftMedx managed to increase its sales volume and maintain its market position. The company continues to focus on leveraging its industry expertise and customer relationships to deliver high-quality healthcare products and services. Trading in the company's shares remains suspended pending the fulfillment of resumption conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Softmedx Healthcare Limited published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2552482692"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2552482692\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2552482692?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-17 21:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2552482692","market":"us","top_or_hot":-1,"title":"SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        SoftMedx Healthcare Limited has published its audited financial results for the year ended 31 December 2024. The company reported a 6.4% increase in revenue, reaching HK$54.6 million, compared to HK$51.3 million in the previous year. This growth was primarily driven by the company's efforts to expand its product offerings by obtaining new product sources. Despite facing challenges from shifting consumer preferences and competitive market conditions, SoftMedx managed to increase its sales volume and maintain its market position. The company continues to focus on leveraging its industry expertise and customer relationships to deliver high-quality healthcare products and services. Trading in the company's shares remains suspended pending the fulfillment of resumption conditions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Softmedx Healthcare Limited published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-17 21:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        SoftMedx Healthcare Limited has published its audited financial results for the year ended 31 December 2024. The company reported a 6.4% increase in revenue, reaching HK$54.6 million, compared to HK$51.3 million in the previous year. This growth was primarily driven by the company's efforts to expand its product offerings by obtaining new product sources. Despite facing challenges from shifting consumer preferences and competitive market conditions, SoftMedx managed to increase its sales volume and maintain its market position. The company continues to focus on leveraging its industry expertise and customer relationships to deliver high-quality healthcare products and services. Trading in the company's shares remains suspended pending the fulfillment of resumption conditions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Softmedx Healthcare Limited published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00648","symbol_name":"京玖康疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL9hHHgx:1","article_id":"2552482692","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2552482692","pubTimestamp":1752760421,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"SoftMedx Healthcare Limited has published its audited financial results for the year ended 31 December 2024. The company reported a 6.4% increase in revenue, reaching HK$54.6 million, compared to HK$51.3 million in the previous year. This growth was primarily driven by the company's efforts to expand its product offerings by obtaining new product sources. Despite facing challenges from shifting consumer preferences and competitive market conditions, SoftMedx managed to increase its sales volume and maintain its market position. The company continues to focus on leveraging its industry expertise and customer relationships to deliver high-quality healthcare products and services. Trading in the company's shares remains suspended pending the fulfillment of resumption conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informationa","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"00648":"京玖康疗"},"translate_title":"SoftMedx Healthcare Limited发布2024财年经审计财务业绩，收入增长6.4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00648":0.9},"content_text":"SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase\n    \n\n        SoftMedx Healthcare Limited has published its audited financial results for the year ended 31 December 2024. The company reported a 6.4% increase in revenue, reaching HK$54.6 million, compared to HK$51.3 million in the previous year. This growth was primarily driven by the company's efforts to expand its product offerings by obtaining new product sources. Despite facing challenges from shifting consumer preferences and competitive market conditions, SoftMedx managed to increase its sales volume and maintain its market position. The company continues to focus on leveraging its industry expertise and customer relationships to deliver high-quality healthcare products and services. Trading in the company's shares remains suspended pending the fulfillment of resumption conditions.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Softmedx Healthcare Limited published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}